NEOGENOMICS, INC. (NEO) FY2026 YTD Q2 Statement of Cash Flows

Statement of Cash Flows

2026-01-01 to 2026-06-30

Swipe to see the full flow
NEOGENOMICS, INC. cash flow reconciliation, Jan 1, 2026 through Jun 30, 2026One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash. Intermediate calculation bars are lighter gray. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Free cash flow is a separate comparison, not an added cash flow. Read chart description and values below for full signed amounts, including zero items.Stock-based compensation → operating reconciliation: $17,852,000.00Depreciation → operating reconciliation: $17,356,000.00Amortization of intangibles → operating reconciliation: $15,267,000.00Accrued compensation → operating reconciliation: $8,685,000.00Non-cash operating lease expense → operating reconciliation: $3,226,000.00Inventories → operating reconciliation: $1,429,000.00Amortization of convertible debt discount → operating reconciliation: $753,000.00Non-cash finance lease amortization → operating reconciliation: $322,000.00Finance lease liabilities → operating reconciliation: $70,000.00Amortization of debt issue costs → operating reconciliation: $20,000.00operating reconciliation → Net cash from operating activities: $11,822,000.00operating reconciliation → Net loss: $14,868,000.00operating reconciliation → Accounts receivable, net: $16,163,000.00operating reconciliation → Gain on debt extinguishment: $11,181,000.00operating reconciliation → Accounts payable and other liabilities: $4,085,000.00operating reconciliation → Prepaid and other assets: $2,852,000.00operating reconciliation → Operating lease liabilities: $2,599,000.00operating reconciliation → Deferred income tax liabilities, net: $1,395,000.00operating reconciliation → Other adjustments: $15,000.00investing reconciliation → Purchases of property and equipment: $13,219,000.00investing reconciliation → Purchase of convertible note: $100,000.00Net cash used in financing activities → financing reconciliation: $12,582,000.00Proceeds from issuance of convertible debt, net of discount → financing reconciliation: $305,434,000.00Proceeds from issuance of common stock under employee stock purchase plan → financing reconciliation: $1,752,000.00Proceeds from issuance of common stock upon exercise of stock options → financing reconciliation: $1,273,000.00Proceeds received from capped call terminations → financing reconciliation: $77,000.00financing reconciliation → Repayment of convertible debt: $262,890,000.00financing reconciliation → Premiums paid for capped call confirmations: $28,747,000.00financing reconciliation → Repurchases of common stock: $25,000,000.00financing reconciliation → Employee taxes paid related to net share settlement of restricted stock: $3,168,000.00financing reconciliation → Repayment of financing leases: $1,313,000.00Net cash used in investing activities → investing reconciliation: $13,319,000.00Beginning cash: Cash, cash equivalents, and restricted cash → Cash sources and uses: $159,618,000.00Net cash from operating activities → Cash sources and uses: $11,822,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash: $145,539,000.00Cash sources and uses → Net cash used in investing activities: $13,319,000.00Cash sources and uses → Net cash used in financing activities: $12,582,000.00Other adjustments: -$15,000.00Other operating, net−$15.00 KOperating lease liabilities: -$2,599,000.00Operating lease liabilities−$2.60 MDepreciation: $17,356,000.00Depreciation expense+$17.36 MNet loss: -$14,868,000.00Net loss−$14.87 MAmortization of debt issue costs: $20,000.00Debt issuance cost amortization+$20.00 KFinance lease liabilities: $70,000.00Finance lease liabilities+$70.00 KAccounts payable and other liabilities: -$4,085,000.00Payables & other liabilities−$4.09 MAmortization of intangibles: $15,267,000.00Intangible amortization+$15.27 MNon-cash operating lease expense: $3,226,000.00Non-cash lease expense+$3.23 MStock-based compensation: $17,852,000.00Stock-based compensation+$17.85 MDeferred income tax liabilities, net: -$1,395,000.00Deferred tax balances−$1.40 MPrepaid and other assets: -$2,852,000.00Prepaid & other assets−$2.85 MAmortization of convertible debt discount: $753,000.00Discount & premium amortization+$753.00 KAccounts receivable, net: -$16,163,000.00Accounts receivable−$16.16 MAccrued compensation: $8,685,000.00Accrued liabilities+$8.69 MInventories: $1,429,000.00Inventories+$1.43 MImpairment charges: $0.00Non-cash finance lease amortization: $322,000.00Finance lease asset amortization+$322.00 KGain on debt extinguishment: -$11,181,000.00Debt extinguishment gain & loss−$11.18 MNet cash from operating activities: $11,822,000.00Operating cash+$11.82 Moperating reconciliation: $64,980,000.00Proceeds from issuance of convertible debt, net of discount: $305,434,000.00Convertible debt issued+$305.43 MRepayment of convertible debt: -$262,890,000.00Convertible debt repaid−$262.89 MPremiums paid for capped call confirmations: -$28,747,000.00Capped call premiums paid−$28.75 MProceeds received from capped call terminations: $77,000.00Capped call termination proceeds+$77.00 KRepurchases of common stock: -$25,000,000.00Common stock repurchases−$25.00 MRepayment of financing leases: -$1,313,000.00Repayment of financing leases−$1.31 MProceeds from issuance of common stock under employee stock purchase plan: $1,752,000.00Common stock issued+$1.75 MProceeds from issuance of common stock upon exercise of stock options: $1,273,000.00Stock option exercises+$1.27 MEmployee taxes paid related to net share settlement of restricted stock: -$3,168,000.00Stock-award tax withholding−$3.17 MNet cash used in financing activities: -$12,582,000.00. Cash required to fund net payments.Financing cash−$12.58 Mfinancing reconciliation: $321,118,000.00Purchases of property and equipment: -$13,219,000.00PP&E purchases−$13.22 MProceeds from maturities of marketable securities: $0.00Business acquisition, net of cash acquired: $0.00Purchase of convertible note: -$100,000.00Notes receivable issued−$100.00 KNet cash used in investing activities: -$13,319,000.00. Cash required to fund net payments.Investing cash−$13.32 Minvesting reconciliation: $13,319,000.00Cash sources and uses: $171,440,000.00Beginning cash: Cash, cash equivalents, and restricted cash: $159,618,000.00Beginning cash$159.62 MEnding cash: Cash, cash equivalents, and restricted cash: $145,539,000.00Ending cash$145.54 MCASH RECONCILIATIONOperatingflowsInvestingflowsFinancingflowsNet loss −$14.87M + net operating adjustments $26.69M = operating cash +$11.82MFree cash flow−$1.40 MOperating cash − cash spent on PP&ECash flow / Net incomeNot meaningfulOperating cash flow ÷ net incomeNet cash change−$14.08 MEnding cash − beginning cash
Chart details

NEOGENOMICS, INC. cash flow reconciliation, Jan 1, 2026 through Jun 30, 2026

Cash flows for Jan 1, 2026 through Jun 30, 2026. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Dec 31, 2025. Ending cash: Jun 30, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Dec 31, 2025
159,618,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
Operating activities
11,822,000 US dollars. Net cash provided.
Net loss
negative 14,868,000 US dollars
Other adjustments
negative 15,000 US dollars
Operating lease liabilities
negative 2,599,000 US dollars
Depreciation
17,356,000 US dollars
Amortization of debt issue costs
20,000 US dollars
Finance lease liabilities
70,000 US dollars
Accounts payable and other liabilities
negative 4,085,000 US dollars
Amortization of intangibles
15,267,000 US dollars
Non-cash operating lease expense
3,226,000 US dollars
Stock-based compensation
17,852,000 US dollars
Deferred income tax liabilities, net
negative 1,395,000 US dollars
Prepaid and other assets
negative 2,852,000 US dollars
Amortization of convertible debt discount
753,000 US dollars
Accounts receivable, net
negative 16,163,000 US dollars
Accrued compensation
8,685,000 US dollars
Inventories
1,429,000 US dollars
Impairment charges
0 US dollars
Non-cash finance lease amortization
322,000 US dollars
Gain on debt extinguishment
negative 11,181,000 US dollars
Investing activities
negative 13,319,000 US dollars. Net cash used.
Purchases of property and equipment
negative 13,219,000 US dollars
Proceeds from maturities of marketable securities
0 US dollars
Business acquisition, net of cash acquired
0 US dollars
Purchase of convertible note
negative 100,000 US dollars
Financing activities
negative 12,582,000 US dollars. Net cash used.
Proceeds from issuance of convertible debt, net of discount
305,434,000 US dollars
Repayment of convertible debt
negative 262,890,000 US dollars
Premiums paid for capped call confirmations
negative 28,747,000 US dollars
Proceeds received from capped call terminations
77,000 US dollars
Repurchases of common stock
negative 25,000,000 US dollars
Repayment of financing leases
negative 1,313,000 US dollars
Proceeds from issuance of common stock under employee stock purchase plan
1,752,000 US dollars
Proceeds from issuance of common stock upon exercise of stock options
1,273,000 US dollars
Employee taxes paid related to net share settlement of restricted stock
negative 3,168,000 US dollars
Operating adjustment reconciliation
64,980,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
financing gross reconciliation
321,118,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
13,319,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
0 US dollars
Ending cash on Jun 30, 2026
145,539,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
Cash sources and uses
171,440,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
negative 14,079,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
Not meaningful. Operating cash flow divided by reconciliation net income for the same period. The ratio is not meaningful when net income is zero or negative.
Operating cash flow
11,822,000 US dollars. Operating cash flow used in the free cash flow calculation.
Cash purchases of property, plant and equipment
13,219,000 US dollars. These cash purchases are already included in investing activities above.
Free cash flow
negative 1,397,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net loss −$14.87M + net operating adjustments $26.69M = operating cash +$11.82M. The loss reduces the earnings basis of the reconciliation; it is not a cash payment. The signed loss remains a deduction at the operating reconciliation junction.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: 11,822,000 US dollars minus 13,219,000 US dollars equals negative 1,397,000 US dollars.
NEOGENOMICS, INC. (NEO) FY2026 YTD Q2 Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!